Pathway Capital Management, LP
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 4, 2026), Pathway Capital Management, LP reported 5 stock positions worth $7.8 million. Its top holding was Braze Class A (BRZE) at 28.3% of the portfolio, followed by Servicetitan Class A (TTAN, 27.3%) and ServiceNow (NOW, 25.1%). Compared with Q3 2025, it opened 5 new positions and sold out of 7. The biggest buy was a new position in Braze Class A (BRZE) and the biggest sale an exit from Hims & Hers Health (HIMS).
- Most Recent 13F
- Q2 2026
- Location
- Irvine, CA
- CIK
- 0001037353
- Portfolio Value
- $7.8M (Q4 2025)
- SEC Filing
- 0001214659-26-001159 ↗ filed Feb 4, 2026
Holdings Value
Holdings 5 stocks · $7.8M
Portfolio Sells Q3 2025 → Q4 2025
| HIMS Hims & Hers Health Inc. | Sold out | 0.00% | −33.26 |
| ACLX Arcellx Inc. | Sold out | 0.00% | −20.60 |
| GDRX Goodrx Holdings Inc. Class A | Sold out | 0.00% | −20.51 |
| CRSP Crispr Therapeutics AG | Sold out | 0.00% | −15.95 |
| PDD PDD Holdings Inc. | Sold out | 0.00% | −4.68 |
| NU Nu Holdings Ltd./Cayman Isl-A | Sold out | 0.00% | −4.64 |
| NEUE Neuehealth Inc. | Sold out | 0.00% | −0.37 |
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $23.9M | RBRK, HOOD, TTAN, BLND |
| Q1 2026 | 2 | $4.3M | LQDA, ETOR |
| Q4 2025 | 5 | $7.8M | BRZE, TTAN, NOW, ETOR, ABNB |
| Q3 2025 | 7 | $20.3M | HIMS, ACLX, GDRX, CRSP, PDD |
| Q2 2025 | 10 | $91.3M | RBRK, TOST, TTAN, BRZE, CXM |
| Q1 2025 | 5 | $17.3M | TEM, VRNA, AMPL, NU, NEUE |
| Q4 2024 | 9 | $100.2M | SPOT, WEAV, S, HOOD, LZ |
| Q3 2024 | 5 | $52.9M | RBRK, SPOT, WEAV, CFLT, NEUE |
| Q2 2024 | 4 | $63.4M | AON, SPOT, DELL, NEUE |
| Q1 2024 | 10 | $107.3M | NFLX, SPOT, NU, TOST, HIMS |